Claims for Patent: 8,536,130

Summary for Patent: 8,536,130

Title:	Use of 1 phenyl-3-dimethylamino-propane compounds for treating neuropathic pain
Abstract:	Use of 1-phenyl-3-dimethylaminopropane compounds for the production of medicaments for treating neuropathic pain, preferably polyneuropathic pain, also preferably diabetic neuropathic pain, more preferably diabetic peripheral neuropathic pain, and furthermore preferably for treating diabetic peripheral neuropathy.
Inventor(s):	Christoph; Thomas (Aachen, DE), Friderichs; Elmar (Stolberg, DE), Koegel; Babette-Yvonne (Langerwehe-Hamich, DE), Meen; Murielle (Ayguesvives, FR)
Assignee:	Gruenenthal GmbH (Aachen, DE)
Application Number:	12/850,208
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,536,130
Patent Claims:	1. A method of treating polyneuropathic pain in a subject suffering therefrom, said method comprising administering to said subject an effective polyneuropathic pain inhibiting amount of (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)phenol or a pharmaceutically acceptable salt thereof. 2. A method according to claim 1, comprising administering a hydrochloride salt of (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)phenol. 3. A method according to claim 1, wherein said polyneuropathic pain is diabetic polyneuropathic pain. 4. A method according to claim 1, wherein said polyneuropathic pain is peripheral polyneuropathic pain. 5. A method according to claim 1, wherein said polyneuropathic pain is peripheral diabetic polyneuropathic pain. 6. A method of treating diabetic polyneuropathy in a subject suffering therefrom, said method comprising administering to said subject a pharmacologically effective amount of (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)phenol or a pharmaceutically acceptable salt thereof.